10466-72-5 Usage
Description
N-(2,4-DINITROPHENYL)-6-AMINOHEXANOIC ACID is a C-nitro compound that consists of hexanoic acid with a (2,4-dinitrophenyl)amino substituent at the C-6 position. It is a unique organic molecule with distinctive chemical properties that make it suitable for various applications, particularly in the field of analytical chemistry.
Uses
Used in Analytical Chemistry Industry:
N-(2,4-DINITROPHENYL)-6-AMINOHEXANOIC ACID is used as an analyte in microfluidic chips for the purpose of conducting chemical analyses and experiments. Its specific chemical structure allows it to be a valuable component in the development and functioning of microfluidic devices, which are miniature analytical systems that handle small volumes of fluids.
The use of N-(2,4-DINITROPHENYL)-6-AMINOHEXANOIC ACID in microfluidic chips enables researchers and scientists to perform high-throughput screening, detect trace amounts of substances, and carry out complex chemical reactions on a small scale. This contributes to advancements in fields such as drug discovery, diagnostics, and environmental monitoring, where precise and efficient analysis is crucial.
Check Digit Verification of cas no
The CAS Registry Mumber 10466-72-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,4,6 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 10466-72:
(7*1)+(6*0)+(5*4)+(4*6)+(3*6)+(2*7)+(1*2)=85
85 % 10 = 5
So 10466-72-5 is a valid CAS Registry Number.
InChI:InChI=1/C18H19N3O6/c1-2-12(13-7-3-5-9-15(13)20(24)25)11-18(19,17(22)23)14-8-4-6-10-16(14)21(26)27/h3-10,12H,2,11,19H2,1H3,(H,22,23)
10466-72-5Relevant articles and documents
Synthesis of DNP-modified GM3-based anticancer vaccine and evaluation of its immunological activities for cancer immunotherapy
Lin, Han,Hong, Haofei,Feng, Lipeng,Shi, Jie,Zhou, Zhifang,Wu, Zhimeng
, p. 4041 - 4044 (2021)
Tumor-associated carbohydrate antigens (TACAs) are attractive targets for vaccine development. In this context, we described a strategy combining artificial TACA and glycoengineering for cancer vaccine development. A 2,4-ditrophenyl (DNP)-modified GM3 int
Pharmacokinetic studies with 3H-labelled synthetic antifibrinolytics
Richter,Markwardt,Kloecking
, p. 851 - 853 (2007/10/02)
In rabbits and rats pharmacokinetic studies on the anti-fibrinolytics 4-aminomethylbenzoic acid (PAMBA), trans-4-aminomethylcyclohexane-1-carboxylic acid (AMCA), and epsilon-aminocaproic acid (EACA) were carried out using the tritium labelled compounds. F